Compendium of Phase-I Mini-SHINE Experiments
Argonne National Laboratory is assisting SHINE Medical Technologies in their efforts to develop the technology to become a domestic Mo-99 producer using low-enriched uranium (LEU). Mini-SHINE experiments are being performed with the high-current electron linear accelerator (linac) at Argonne. The target solution is a 90-150 g-U/L LEU uranyl sulfate at pH 1. In Phase 1, the convertor was tantalum with a maximum beam power on the convertor of 10 kW, and the target solution was limited to 5 L. This configuration generated a peak fission power density of 0.05 W/mL. Nine experiments were performed between February and October 2015. Results are reported and discussed for each experiment regarding the off-gas analysis system, the sampling and Mo-recovery operation, and the Mo-product concentration and purification system. In Phase 2, the convertor will be depleted uranium; beam power will increase to 20 kW; and the solution volume will be 18 L. This configuration will generate a fission power density of up to 1 W/mL.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA) - Office of Defense Nuclear Nonproliferation - Office of Material Management and Minimization (M3)
- DOE Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1342169
- Report Number(s):
- ANL/NE-16/39; 131828
- Country of Publication:
- United States
- Language:
- English
Similar Records
SHINE and Mini-SHINE Column Designs for Recovery of Mo from 140 g-U/L Uranyl Sulfate
Direct Down-scale Experiments of Concentration Column Designs for SHINE Process